NCT00728897 - A Healthy Volunteer Study to Investigate the Relative Bioavailability of Two Forms of GSK598809 Capsules. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 2, 2008

Primary Completion Date

July 29, 2008

Study Completion Date

July 29, 2008

Conditions

Substance Dependence

Interventions

DRUG

GSK598809 new formulation

GSK598809 new formulation will be available as an immediate release capsule with a single dose of 100 milligrams, administered orally with 240 milliliters of water.

DRUG

GSK598809 old formulation

GSK598809 old formulation will be available as an immediate release capsule with a single dose of 25 milligrams, administered orally with 240 milliliters of water.

Trial Locations (1)

SE1 1YR

GSK Investigational Site, London